149 related articles for article (PubMed ID: 15834022)
1. The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.
Greer JM; Pender MP
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):656-62. PubMed ID: 15834022
[TBL] [Abstract][Full Text] [Related]
2. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
[TBL] [Abstract][Full Text] [Related]
3. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
Aláez C; Corona T; Ruano L; Flores H; Loyola M; Gorodezky C
Acta Neurol Scand; 2005 Nov; 112(5):317-22. PubMed ID: 16218914
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis.
de la Concha EG; Arroyo R; Crusius JB; Campillo JA; Martin C; Varela de Seijas E; Peña AS; Clavería LE; Fernandez-Arquero M
J Neuroimmunol; 1997 Dec; 80(1-2):172-8. PubMed ID: 9413274
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis.
Mattey DL; Dawes PT; Gonzalez-Gay MA; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE
J Rheumatol; 2001 Feb; 28(2):232-9. PubMed ID: 11246655
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis.
Foley PJ; McGrath DS; Puscinska E; Petrek M; Kolek V; Drabek J; Lympany PA; Pantelidis P; Welsh KI; Zielinski J; du Bois RM
Am J Respir Cell Mol Biol; 2001 Sep; 25(3):272-7. PubMed ID: 11588003
[TBL] [Abstract][Full Text] [Related]
7. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
[TBL] [Abstract][Full Text] [Related]
8. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
[TBL] [Abstract][Full Text] [Related]
9. Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value.
Hong GH; Park MH; Takeuchi F; Oh MD; Song YW; Nabeta H; Nakano K; Ito K; Park KS
J Rheumatol; 1996 Oct; 23(10):1699-703. PubMed ID: 8895143
[TBL] [Abstract][Full Text] [Related]
10. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-DR with progressive systemic sclerosis in Japanese.
Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
[TBL] [Abstract][Full Text] [Related]
12. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
Van der Walt A; Stankovich J; Bahlo M; Taylor BV; Van der Mei IA; Foote SJ; Rubio JP; Kilpatrick TJ; Butzkueven H
Mult Scler; 2011 Mar; 17(3):344-52. PubMed ID: 21149397
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
[TBL] [Abstract][Full Text] [Related]
16. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS.
Cocco E; Sotgiu A; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Contu P; Marrosu MG
Neurology; 2005 Feb; 64(3):564-6. PubMed ID: 15699400
[TBL] [Abstract][Full Text] [Related]
18. HLA Class II genotypes associated with early-onset periodontitis: DQB1 molecule primarily confers susceptibility to the disease.
Ohyama H; Takashiba S; Oyaizu K; Nagai A; Naruse T; Inoko H; Kurihara H; Murayama Y
J Periodontol; 1996 Sep; 67(9):888-94. PubMed ID: 8884646
[TBL] [Abstract][Full Text] [Related]
19. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
[TBL] [Abstract][Full Text] [Related]
20. Is typing for HLA class II alleles beneficial in Indian children with idiopathic nephrotic syndrome?
Gulati S; Tripathi P; Patil SJ; Sharma RK; Agarwal S
Pediatr Nephrol; 2007 Apr; 22(4):528-32. PubMed ID: 17180363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
